Skip to main content

Market Overview

Why Mirati's Stock Is Trading Higher Today

Share:
Why Mirati's Stock Is Trading Higher Today

Mirati Therapeutics (NASDAQ: MRTX) shares are trading higher on Monday following positive preliminary data for MRTX849 for patients with advanced non-small cell lung cancer.

Mirati Therapeutics is an American biotechnology company. The company's medical focus is precision medicine: genetically targeted oncology therapeutics for selected patients. Mirati's drug candidates target specific genetic and epigenetic drivers of cancer.

Mirati Therapeutics shares traded up 13.97% to $205.36 on Monday at the time of publication. The stock has a 52-week high of $211.50 and a 52-week low of $66.01.

 

Related Articles (MRTX)

View Comments and Join the Discussion!

Posted-In: why it's movingNews

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com